Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1978 1
1979 1
1984 1
1985 1
1991 3
1993 2
1994 1
1995 2
1996 1
2002 1
2004 1
2007 1
2008 1
2009 2
2010 2
2011 1
2012 1
2015 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Scanning ultrahigh vacuum reflectometer.
Huen T, Irani GB, Wooten F. Huen T, et al. Among authors: wooten f. Appl Opt. 1971 Mar 1;10(3):552-6. doi: 10.1364/AO.10.000552. Appl Opt. 1971. PMID: 20094489
Technology transfer in medicine.
Brown JN Jr, Wooten FT, Fischer WA. Brown JN Jr, et al. Among authors: wooten ft. CRC Crit Rev Bioeng. 1979 Dec;4(1):45-79. CRC Crit Rev Bioeng. 1979. PMID: 393462 Review. No abstract available.
Natural history of multiple system atrophy in the USA: a prospective cohort study.
Low PA, Reich SG, Jankovic J, Shults CW, Stern MB, Novak P, Tanner CM, Gilman S, Marshall FJ, Wooten F, Racette B, Chelimsky T, Singer W, Sletten DM, Sandroni P, Mandrekar J. Low PA, et al. Among authors: wooten f. Lancet Neurol. 2015 Jul;14(7):710-9. doi: 10.1016/S1474-4422(15)00058-7. Epub 2015 May 27. Lancet Neurol. 2015. PMID: 26025783 Free PMC article.
Potential outcome measures and trial design issues for multiple system atrophy.
May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, Marshall FJ, Wooten F, Shults CW; North American Multiple System Atrophy Study Group. May S, et al. Among authors: wooten f. Mov Disord. 2007 Dec;22(16):2371-7. doi: 10.1002/mds.21734. Mov Disord. 2007. PMID: 17914727 Free article.
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium. Pankratz N, et al. Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687. Ann Neurol. 2012. PMID: 22451204 Free PMC article.
Method of constrained global optimization.
Altschuler EL, Williams TJ, Ratner ER, Dowla F, Wooten F. Altschuler EL, et al. Among authors: wooten f. Phys Rev Lett. 1994 Apr 25;72(17):2671-2674. doi: 10.1103/PhysRevLett.72.2671. Phys Rev Lett. 1994. PMID: 10055947 No abstract available.
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
Schwid SR, Bausch J, Oakes D, Schuchter L, Tanner C, Forrest M, Lang AE, Shoulson I; PSG PRECEPT Investigators; Shoulson I, Hyson C, Oakes D, Flagg E, Rudolph A, Kieburtz K, Lang A, Fahn S, Gauger L, Goetz C. Schwid SR, et al. Mov Disord. 2010 Sep 15;25(12):1801-8. doi: 10.1002/mds.23006. Mov Disord. 2010. PMID: 20669311 Clinical Trial.
25 results